Guangkang Biochemical: Shareholder Rui Hongkai Silver One has reduced its holdings by 2.6757%

Guangkang Bio announced that a specific shareholder, Qingcheng Ruihong Kai Yin No.1 Equity Investment Fund Partnership Enterprise, completed a reduction in holdings from February 25, 2026 to February 26, 2026, with a total reduction of 1.98 million shares, accounting for 2.6757% of the total share capital. Among them, 740,000 shares were reduced through centralized bidding trading at an average price of 46.98 yuan per share, accounting for 1.0000%; 1.24 million shares were reduced through block trades at an average price of 44.62 yuan per share, accounting for 1.6757%. After the reduction, the shareholder holds 0 shares, accounting for 0%.